Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00516698 · ClinicalTrials.gov registry record
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
A clinical trial of Breast Cancer, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 140
- Enrollment target
- 20
- Study locations
NCT00516698 is a study of Breast Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 140 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 20 study locations across 2 states.
The verdict
NCT00516698, a study of Breast Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Studying changes in breast density and blood hormone levels in women receiving anastrozole or exemestane for breast cancer may help doctors learn more about the long-term effects of treatment and may help the study of breast cancer in the future. PURPOSE: This clinical trial is studying changes in breast density and blood hormone levels in postmenopausal women receiving anastrozole or exemestane for breast cancer.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- GENETIC polymorphism analysis
- OTHER high performance liquid chromatography
- PROCEDURE radiomammography
Study Locations (20)
Illinois
- Rush-Copley Cancer Care Center - Aurora
- St. Joseph Medical Center - Bloomington
- Graham Hospital - Canton
- Memorial Hospital - Carthage
- St. Anthony's Memorial Hospital - Effingham
- Eureka Community Hospital - Eureka
- Galesburg Clinic, PC - Galesburg
- Galesburg Cottage Hospital - Galesburg
- Mason District Hospital - Havana
- Hopedale Medical Complex - Hopedale
- Joliet Oncology-Hematology Associates, Limited - West - Joliet
- McDonough District Hospital - Macomb
- Trinity Cancer Center at Trinity Medical Center - 7th Street Campus - Moline
- - Moline
- BroMenn Regional Medical Center - Normal
- Community Cancer Center - Normal
- Community Hospital of Ottawa - Ottawa
- Oncology Hematology Associates of Central Illinois, PC - Ottawa - Ottawa
- Cancer Treatment Center at Pekin Hospital - Pekin
Georgia
- MBCCOP - Medical College of Georgia Cancer Center - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00516698
The ClinicalTrials.gov registry entry for NCT00516698 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT00516698 reports 20 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Georgia.
Frequently Asked Questions
What is clinical trial NCT00516698 about?
NCT00516698 is a clinical study titled "Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer". RATIONALE: Studying changes in breast density and blood hormone levels in women receiving anastrozole or exemestane for breast cancer may help doctors learn more about the long-term effects of treatment and may help the study of breast cancer in the future. PURPOSE: This clinical trial is studying ...
What is the current status of trial NCT00516698?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2007-09. Estimated completion is 2009-12.
What conditions does trial NCT00516698 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT00516698?
The interventions under investigation include: laboratory biomarker analysis (OTHER), polymorphism analysis (GENETIC), high performance liquid chromatography (OTHER), radiomammography (PROCEDURE).
Who is sponsoring clinical trial NCT00516698?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00516698 being conducted?
This trial has 20 study locations across Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.